Douglas Tsao
Stock Analyst at HC Wainwright & Co.
(2.10)
# 2,844
Out of 4,883 analysts
513
Total ratings
34.45%
Success rate
-3.73%
Average return
Main Sectors:
Stocks Rated by Douglas Tsao
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IRON Disc Medicine | Reiterates: Buy | $118 | $54.75 | +115.53% | 16 | Jul 3, 2025 | |
| ARGX argenx SE | Reiterates: Buy | $720 | $543.48 | +32.48% | 39 | Jul 1, 2025 | |
| CRNX Crinetics Pharmaceuticals | Reiterates: Buy | $81 | $29.80 | +171.81% | 24 | Jun 27, 2025 | |
| ROIV Roivant Sciences | Reiterates: Buy | $18 | $10.99 | +63.79% | 20 | Jun 18, 2025 | |
| SAGE Sage Therapeutics | Reiterates: Neutral | $12 | $9.20 | +30.43% | 23 | Jun 17, 2025 | |
| CABA Cabaletta Bio | Reiterates: Buy | $25 | $1.63 | +1,433.74% | 26 | Jun 11, 2025 | |
| PTGX Protagonist Therapeutics | Reiterates: Buy | $80 | $51.05 | +56.71% | 33 | Jun 3, 2025 | |
| XENE Xenon Pharmaceuticals | Reiterates: Buy | $53 | $33.26 | +59.35% | 5 | May 13, 2025 | |
| PRAX Praxis Precision Medicines | Reiterates: Buy | $105 | $47.26 | +122.18% | 23 | May 1, 2025 | |
| CHRS Coherus Oncology | Reiterates: Buy | $7 | $0.81 | +764.20% | 25 | Apr 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $14 | $4.82 | +190.46% | 17 | Apr 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $34 | $15.67 | +116.98% | 16 | Apr 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $27 | $9.27 | +191.26% | 27 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $19 | $13.82 | +37.48% | 4 | Apr 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $12 | $2.40 | +400.00% | 17 | Apr 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $18 | $3.97 | +353.40% | 14 | Mar 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $51 | $16.95 | +200.88% | 22 | Mar 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $18 | $0.82 | +2,090.85% | 7 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $54 | $14.63 | +269.10% | 14 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $57 | $18.26 | +212.16% | 26 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $11.15 | +34.53% | 15 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $5 | $1.65 | +203.03% | 14 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $3 | $1.78 | +68.54% | 16 | Feb 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $46 | $28.85 | +59.45% | 23 | Feb 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8 | $4.20 | +90.48% | 9 | Nov 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $360 | $0.84 | +42,879.94% | 8 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $10 | $1.18 | +747.46% | 5 | Jun 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $23 → $10 | $29.73 | -66.36% | 7 | Dec 9, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $168 → $182 | $150.10 | +21.25% | 4 | Feb 20, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $19 | $7.10 | +164.08% | 2 | Jan 23, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $25 → $18 | $28.00 | -35.71% | 3 | Aug 29, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Underweight | $8 | $17.01 | -52.97% | 7 | Jun 11, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $52 | $23.22 | +123.94% | 2 | Jun 11, 2019 |
Disc Medicine
Jul 3, 2025
Reiterates: Buy
Price Target: $118
Current: $54.75
Upside: +115.53%
argenx SE
Jul 1, 2025
Reiterates: Buy
Price Target: $720
Current: $543.48
Upside: +32.48%
Crinetics Pharmaceuticals
Jun 27, 2025
Reiterates: Buy
Price Target: $81
Current: $29.80
Upside: +171.81%
Roivant Sciences
Jun 18, 2025
Reiterates: Buy
Price Target: $18
Current: $10.99
Upside: +63.79%
Sage Therapeutics
Jun 17, 2025
Reiterates: Neutral
Price Target: $12
Current: $9.20
Upside: +30.43%
Cabaletta Bio
Jun 11, 2025
Reiterates: Buy
Price Target: $25
Current: $1.63
Upside: +1,433.74%
Protagonist Therapeutics
Jun 3, 2025
Reiterates: Buy
Price Target: $80
Current: $51.05
Upside: +56.71%
Xenon Pharmaceuticals
May 13, 2025
Reiterates: Buy
Price Target: $53
Current: $33.26
Upside: +59.35%
Praxis Precision Medicines
May 1, 2025
Reiterates: Buy
Price Target: $105
Current: $47.26
Upside: +122.18%
Coherus Oncology
Apr 29, 2025
Reiterates: Buy
Price Target: $7
Current: $0.81
Upside: +764.20%
Apr 28, 2025
Reiterates: Buy
Price Target: $14
Current: $4.82
Upside: +190.46%
Apr 23, 2025
Reiterates: Buy
Price Target: $34
Current: $15.67
Upside: +116.98%
Apr 10, 2025
Reiterates: Buy
Price Target: $27
Current: $9.27
Upside: +191.26%
Apr 3, 2025
Reiterates: Buy
Price Target: $19
Current: $13.82
Upside: +37.48%
Apr 1, 2025
Reiterates: Buy
Price Target: $12
Current: $2.40
Upside: +400.00%
Mar 20, 2025
Reiterates: Buy
Price Target: $18
Current: $3.97
Upside: +353.40%
Mar 19, 2025
Reiterates: Buy
Price Target: $51
Current: $16.95
Upside: +200.88%
Mar 7, 2025
Reiterates: Buy
Price Target: $18
Current: $0.82
Upside: +2,090.85%
Mar 4, 2025
Reiterates: Buy
Price Target: $54
Current: $14.63
Upside: +269.10%
Mar 3, 2025
Reiterates: Buy
Price Target: $57
Current: $18.26
Upside: +212.16%
Feb 27, 2025
Reiterates: Buy
Price Target: $15
Current: $11.15
Upside: +34.53%
Feb 26, 2025
Reiterates: Neutral
Price Target: $5
Current: $1.65
Upside: +203.03%
Feb 18, 2025
Maintains: Buy
Price Target: $30 → $3
Current: $1.78
Upside: +68.54%
Feb 13, 2025
Reiterates: Neutral
Price Target: $46
Current: $28.85
Upside: +59.45%
Nov 7, 2024
Reiterates: Buy
Price Target: $8
Current: $4.20
Upside: +90.48%
Oct 1, 2024
Reiterates: Buy
Price Target: $360
Current: $0.84
Upside: +42,879.94%
Jun 7, 2022
Downgrades: Neutral
Price Target: $10
Current: $1.18
Upside: +747.46%
Dec 9, 2021
Maintains: Neutral
Price Target: $23 → $10
Current: $29.73
Upside: -66.36%
Feb 20, 2020
Maintains: Equal-Weight
Price Target: $168 → $182
Current: $150.10
Upside: +21.25%
Jan 23, 2020
Downgrades: Neutral
Price Target: $19
Current: $7.10
Upside: +164.08%
Aug 29, 2019
Maintains: Underweight
Price Target: $25 → $18
Current: $28.00
Upside: -35.71%
Jun 11, 2019
Initiates: Underweight
Price Target: $8
Current: $17.01
Upside: -52.97%
Jun 11, 2019
Initiates: Overweight
Price Target: $52
Current: $23.22
Upside: +123.94%